Ligand Pharmaceuticals trades on Nasdaq, receiving analyst upgrades from Citigroup and Bank of America.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ligand Pharmaceuticals trades on Nasdaq, receiving analyst upgrades from Citigroup and Bank of America.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Regeneron Pharmaceuticals stock is traded on the Nasdaq exchange.
- Citigroup raised its rating on Innate Pharma stock, which trades on the Nasdaq exchange. Leerink Partners also upgraded the rating. MarketBeat aggregates the rating data.
- DiaMedica Therapeutics, Inc. shares were traded on the Nasdaq exchange on October 14, 2026.
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.
- Shares of Syndax Pharmaceuticals were traded on the Nasdaq stock exchange on August 12, 2026.